Axe Compute Inc (AGPU)
NASDAQ:AGPU
Want to see AGPU full AI Analyst Report?
AGPU Stock Chart & Stats
$7.20
-$0.38(-22.49%)
At close: 4:00 PM EST
$7.20
-$0.38(-22.49%)
Day’s Range― - ―
52-Week Range$1.03 - $32.10
Previous CloseN/A
VolumeN/A
Average Volume (3M)173.82K
Market Cap
$70.00M
Enterprise Value$15.65M
Total Cash (Recent Filing)$6.93M
Total Debt (Recent Filing)$1.43M
Price to Earnings (P/E)―
Beta1.37
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-144.81
Shares Outstanding10,819,094
10 Day Avg. Volume72,596
30 Day Avg. Volume173,821
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.61
Price to Sales (P/S)994.73
P/FCF Ratio-2.93
Enterprise Value/Market Cap0.22
Enterprise Value/Revenue311.20
Enterprise Value/Gross Profit-95.70
Enterprise Value/Ebitda-0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.2
Revenue Forecast (FY)$15.45M
Bulls Say, Bears Say
Bulls Say
TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.
Bears Say
Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.
Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.
Axe Compute Inc News
AGPU FAQ
What was Axe Compute Inc’s price range in the past 12 months?
Axe Compute Inc lowest stock price was $1.03 and its highest was $32.10 in the past 12 months.
What is Axe Compute Inc’s market cap?
Axe Compute Inc’s market cap is $70.00M.
When is Axe Compute Inc’s upcoming earnings report date?
Axe Compute Inc’s upcoming earnings report date is Aug 06, 2026 which is in 40 days.
How were Axe Compute Inc’s earnings last quarter?
Currently, no data Available
Is Axe Compute Inc overvalued?
According to Wall Street analysts Axe Compute Inc’s price is currently Overvalued.
Does Axe Compute Inc pay dividends?
Axe Compute Inc does not currently pay dividends.
What is Axe Compute Inc’s EPS estimate?
Axe Compute Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Axe Compute Inc have?
Axe Compute Inc has 10,819,094 shares outstanding.
What happened to Axe Compute Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Axe Compute Inc?
Currently, no hedge funds are holding shares in AGPU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Axe Compute Inc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.50%
12-Months-Change
Fundamentals
Return on Equity
-9999.00%
Trailing 12-Months
Asset Growth
670.63%
Trailing 12-Months
Company Description
Axe Compute Inc
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
AGPU Company Deck
AGPU Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a contrast between a weak, transitional Q1 driven by legacy revenue decline, token mark-to-market losses, and higher operating cash use, versus significant forward-looking commercial momentum: a $260 million signed build that will generate roughly $21 million in quarterly revenue when live, a large (>36,000 GPU, $4.3B) advanced pipeline, and a business model that converts deals into owned, amortizable GPU assets. Given management’s emphasis on recent large contract wins, an expanding pipeline and the expectated revenue ramp in subsequent quarters, the positives around future revenue visibility and asset-building appear to materially outweigh the near-term accounting losses and cash burn outlined for Q1.View all AGPU earnings summariesTechnical Analysis
Ownership Overview
1.93% Insiders
0.30% Mutual Funds
2.35% Other Institutional Investors
95.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---